<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03251729</url>
  </required_header>
  <id_info>
    <org_study_id>17D.164</org_study_id>
    <nct_id>NCT03251729</nct_id>
  </id_info>
  <brief_title>Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix</brief_title>
  <acronym>COLORS</acronym>
  <official_title>Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the efficacy of cervical cerclage in prevention of
      spontaneous preterm birth in singleton pregnancies with a short transvaginal cervical length
      (&lt;=25mm) and without prior spontaneous preterm birth
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Singleton pregnancies between 18 0/7 to 23 6/7 weeks without a prior spontaneous preterm
      birth found to have a short transvaginal ultrasound cervical length (&lt;=25mm) and meeting all
      other eligibility criteria will be randomized to either cervical cerclage or control (no
      cerclage). Aside from cerclage placement, management of included women will be the same
      including recommendation for daily vaginal progesterone 200mg suppository or 90mg gel from
      randomization until 36 6/7 weeks. The primary outcome will be the incidence of spontaneous
      preterm birth &lt;35 weeks
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized trial of cerclage versus no cerclage in singleton pregnancies without prior spontaneous preterm birth and with a short transvaginal ultrasound cervical length</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preterm birth &lt;35 weeks</measure>
    <time_frame>At delivery</time_frame>
    <description>Incidence of spontaneous preterm birth less than 35 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preterm birth &lt;37 weeks, &lt;34 weeks, &lt;32 weeks, &lt;28 weeks, &lt;24 weeks</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean gestational age at delivery</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histologically proven clinical chorioamnionitis</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: birth weight</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: low birth weight (&lt;2500g),</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: admission to intensive care nursery</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: length of neonatal hospital admission</measure>
    <time_frame>at least 30 days after delivery, up to 6 months after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: respiratory distress syndrome</measure>
    <time_frame>at least 30 days after delivery, up to 6 months after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: IVH grade 3 or 4</measure>
    <time_frame>at least 30 days after delivery, up to 6 months after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: retinopathy of prematurity</measure>
    <time_frame>at least 30 days after delivery, up to 6 months after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: bronchopulmonary dysplasia</measure>
    <time_frame>at least 30 days after delivery, up to 6 months after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcomes: neonatal mortality</measure>
    <time_frame>28 days after delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">206</enrollment>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>Cerclage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cervical cerclage placement along with vaginal progesterone 200mg suppository or 90mg gel nightly from randomization until 36 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Vaginal progesterone 200mg suppository or 90mg gel nightly from randomization until 36 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cervical cerclage</intervention_name>
    <description>Transvaginal cervical cerclage placed between 18 0/7 - 23 6/7 weeks</description>
    <arm_group_label>Cerclage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vaginal progesterone</intervention_name>
    <description>Vaginal progesterone 200mg suppository or 90mg gel nightly from randomization until 36 weeks</description>
    <arm_group_label>Cerclage</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 year old or older

          -  Singleton pregnancy

          -  No prior SPTB or second trimester losses between 160 and 366 weeks

          -  TVU CL â‰¤25mm between 180 and 236 weeks

        Exclusion Criteria:

          -  Multiple pregnancy

          -  Prior SPTB or second trimester losses between 160 and 366 weeks

          -  Cerclage in situ

          -  Painful regular uterine contraction and/or preterm labor

          -  Rupture membranes

          -  Major fetal anomaly or aneuploidy

          -  Active vaginal bleeding

          -  Placenta previa and/or accreta

          -  Cervical dilation &gt;1.0 cm and/or visible membranes by pelvic exam

          -  Suspicion of chorioamnionitis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Patients must be pregnant to be enrolled. Self-represented gender identity is NOT a basis of eligibility</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vincenzo Berghella, MD</last_name>
    <phone>215-955-9200</phone>
    <email>vincenzo.berghella@jefferson.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rupsa C Boelig, MD</last_name>
    <phone>215-955-9196</phone>
    <email>rupsa.boelig@jefferson.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rupsa C Boelig, MD</last_name>
      <email>rupsa.boelig@jefferson.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Berghella V, Ciardulli A, Rust OA, To M, Otsuki K, Althuisius S, Nicolaides KH, Roman A, Saccone G. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017 Nov;50(5):569-577. doi: 10.1002/uog.17457. Epub 2017 Oct 5. Review.</citation>
    <PMID>28295722</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2017</study_first_submitted>
  <study_first_submitted_qc>August 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2017</study_first_posted>
  <last_update_submitted>August 14, 2017</last_update_submitted>
  <last_update_submitted_qc>August 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cerclage, preterm birth, short cervix</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

